Overview

Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors

Status:
Terminated
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this study is to test the individual and combined effect of transdermal testosterone and/or Vitamin D in reducing fall risk and improve function in pre-frail hypogonadal senior men.
Phase:
Phase 3
Details
Lead Sponsor:
University of Zurich
Collaborators:
Besins Healthcare (funding: investigator-initiated and independent grant)
Cantonal Hospital of St. Gallen (PD Dr. Thomas Müntzer)
Centre on Ageing and Mobility (Dr. Andreas Egli)
Dr. Wild & Co. (funding: investigator-initiated and independent grant)
Swiss National Science Foundation
Swiss National Science Foundation (funding: primary funding source)
Tufts University Jean Mayer USDA Human Nutrition Research Center on Aging
University Hospital of Zurich, Dept. of Geriatrics (Prof. Robert Theiler, Dr. Gregor Freystaetter)
University Hospital, Zürich
Treatments:
Cholecalciferol
Ergocalciferols
Methyltestosterone
Pharmaceutical Solutions
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
Vitamin D
Vitamins